Jurata

Jurata Thin Film, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2014. The company focuses on innovative thermostable formulations that simplify the supply chain for biologics, vaccines, gene therapies, and advanced therapeutics by reducing or eliminating the need for cold chain logistics. Jurata aims to make the manufacturing, distribution, and administration of vaccines and biologics more accessible, particularly in remote areas.

Jurata's core technology preserves the three-dimensional structure of biologic materials without the need for lyophilization. Their formulations are available in various formats, including thin films and liquids, and support needle-free administration methods. This technology applies to a wide range of products, including vaccines, biologics, and gene therapies. The company collaborates with drug developers to enhance product attributes and address formulation challenges, contributing to the development of first-in-class therapies.